{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-121714","form_type":"8-K","ticker":"NMRA","cik":"0001885522","company_name":"Neumora Therapeutics, Inc.","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.371713+00:00","generated_at":"2026-05-21T03:42:27.643976+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Neumora receives Nasdaq minimum bid price deficiency notice; has until Nov 10, 2025 to cure","bullets":["Nasdaq notified Neumora on May 14, 2025 that its stock failed to meet the $1.00 minimum bid price requirement.","Company has 180 calendar days, until November 10, 2025, to regain compliance by closing at $1.00+ for 10 consecutive business days.","If not compliant by Nov 10, 2025, Neumora may seek transfer to Nasdaq Capital Market and additional cure period.","Board approved a reverse stock split (1-for-5 to 1-for-30) subject to stockholder vote at Annual Meeting on May 28, 2025.","Neumora intends to monitor bid price and consider options including the reverse split to maintain listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-121714","json":"https://secwatch.observer/filing/0001193125-25-121714.json","markdown":"https://secwatch.observer/filing/0001193125-25-121714.md","text":"https://secwatch.observer/filing/0001193125-25-121714.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1885522/000119312525121714/0001193125-25-121714-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1885522/000119312525121714/d933150d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:42:27.643976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}